Portfolio (Quarterly)
Guide ↗
GILEAD SCIENCES, INC.
· CIK 0000882095| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | RCUS | Arcus Biosciences Inc. | Healthcare | 31,424,760.0 | $968.8M | 58.76% | — | — | $30.83 | -1.6% |
| 2 | GLPG | Lakefront Biotherapeutics | Healthcare | 16,707,477.0 | $500.2M | 30.34% | — | — | $29.94 | -6.5% |
| 3 | — | Assembly Biosciences Inc. | — | 4,977,089.0 | $136.8M | 8.29% | +472K | +10.5% | $27.48 | — |
| 4 | KYTX | Kyverna Therapeutics Inc. | Healthcare | 4,126,119.0 | $36.8M | 2.23% | — | — | $8.91 | -5.5% |
| 5 | — | Xilio Therapeutics Inc. | — | 650,389.0 | $6.2M | 0.38% | -8.5M | -92.9% | $9.58 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%